BENCHMARK ANIMAL HEALTH LIMITED
Get an alert when BENCHMARK ANIMAL HEALTH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-06-30 (in 1mo)
Last filed for 2024-09-30
Confirmation statement due
2026-11-15 (in 6mo)
Last made up 2025-11-01
Watchouts
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Accounts
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors' have reviewed the Group's forecast for a period of at least 12 months from the date of approval of the financial statements and concluded that the Company should be able to continue to operate as a going concern. Further details are provided in note 2 to the financial statements.”
Group structure
- BENCHMARK ANIMAL HEALTH LIMITED · parent
- Benchmark Animal Health US, Inc 100%
- Benchmark Animal Health Inc 100%
- Benchmark R&D (Thailand) Limited 100%
- Benchmark Animal Health Chile SpA 100%
Significant events
- “The Health division underwent a significant restructuring in FY24 to create a sustainable and profitable business, concentrating on the core sea lice solution, Salmosan® Vet, while maintaining the capability to deploy Ectosan® Vet and CleanTreat® in the future.”
- “Transitioned CleanTreat® from the PSV model to a future customer-owned infrastructure model, reducing fixed costs and capital exposure.”
- “Successfully demobilised both CleanTreat® PSVs in Q2 and Q3, leading to significant cost savings.”
- “capitalised development costs relating to Ectosan® Vet/CleanTreat® of £13.3m were impaired to nil.”
- “On 25 November, an agreement was signed for the Group to sell the whole Genetics business for consideration of up to £260m, with £230m received up front and up to £30m earnout receivable in three years. Completion of the deal took place on 31 March 2025”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HUGO, Pierre Joseph Jean | Director | 2025-09-30 | Dec 1971 | Belgian |
| ROSENLUND, Sindre Frivik | Director | 2025-09-30 | Jan 1992 | Norwegian |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BONNEY, Roland James | Director | 2014-01-31 | 2019-09-30 |
| DAVY, Christopher John | Director | 2017-01-05 | 2021-03-23 |
| KNOTT, Stephen Wesley Andrew | Director | 2018-10-02 | 2020-05-31 |
| MAGUIRE, Septima | Director | 2021-03-23 | 2025-07-31 |
| MARSHALL, John William | Director | 2014-01-31 | 2023-06-30 |
| MATHIASSEN, Fredrik Andre | Director | 2025-07-31 | 2025-09-30 |
| PLAMPIN, Mark James | Director | 2014-01-31 | 2019-12-20 |
| PYE, Malcolm David Foster | Director | 2014-01-31 | 2019-11-30 |
| WARDLE, Robin Glevum | Director | 2017-01-05 | 2019-07-02 |
| WILLIKSEN, Trond | Director | 2020-09-28 | 2025-08-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Benchmark Animal Health Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 75 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-03 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-03 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-01 | AP01 | officers | Appoint person director company with name date | |
| 2025-08-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-07 | AA | accounts | Accounts with accounts type full | |
| 2025-04-02 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-12-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-09 | CH01 | officers | Change person director company with change date | |
| 2024-05-16 | AA | accounts | Accounts with accounts type full | |
| 2023-12-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-06 | AA | accounts | Accounts with accounts type full | |
| 2023-06-30 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-29 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2022-11-24 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-11-21 | CH01 | officers | Change person director company with change date | |
| 2022-11-14 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one